Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples from Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease

BACKGROUND: Biomarker identification is becoming increasingly important for the development of personalized or stratified therapies. Metabolomics yields biomarkers indicative of phenotype that can be used to characterize transitions between health and disease, disease progression and therapeutic res...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lodi, Alessia, Tiziani, Stefano, Khanim, Farhat L., Günther, Ulrich L., Viant, Mark R., Morgan, Gareth J., Bunce, Christopher M., Drayson, Mark T.
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2013
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3576408/
https://ncbi.nlm.nih.gov/pubmed/23431376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0056422
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires